[en] [en] AIMS: To assess characteristics and outcome of patients treated with Impella for acute myocardial infarction (AMI) complicated by severe cardiogenic shock (CS) or cardiac arrest (CA).
METHODS AND RESULTS: From 2008 through 2017, 92 patients with AMI complicated by CS were treated with Impella. Survival varied according to clinical presentation. Patients in cardiogenic shock without CA had a 75% 30-day survival. Patients with CA and return of spontaneous circulation (ROSC) had a 43% survival and those with CA and ongoing cardio-pulmonary resuscitation (CPR) had a 6% 30-day survival. Age, pre-existing hypertension, coronary disease, ventilatory support and use of adrenergic agents were associated with worse prognosis. Complications were predominantly access site related.
CONCLUSIONS: In this registry of patients with AMICS treated with Impella, hypertension and older age were found to be negatively predictive for survival. Patients without CA had the highest 30-day survival. In patients with ROSC, survival was strongly related to age and comorbidity. Patients with ongoing CPR had very high mortality.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Davidsen, Cédric ; Université de Liège - ULiège > Département des sciences cliniques ; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway. Electronic address: cedric.davidsen@ihelse.net
Packer, Erik J S; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Løland, Kjetil H; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Rotevatn, Svein; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Nygreen, Else L; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Eriksen, Erlend; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Øksnes, Anja; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Herstad, Jon; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Haaverstad, Rune; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway, Faculty of Medicine, University of Bergen, Bergen, Norway
Bleie, Øyvind; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
Tuseth, Vegard; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway, Faculty of Medicine, University of Bergen, Bergen, Norway
Language :
English
Title :
Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data.
Goldberg, R.J., Gore, J.M., Alpert, J.S., et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 325 (1991), 1117–1122.
Goldberg, R.J., Makam, R.C., Yarzebski, J., McManus, D.D., Lessard, D., Gore, J.M., Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes 9 (2016), 117–125.
Goldberg, R.J., Spencer, F.A., Gore, J.M., Lessard, D., Yarzebski, J., Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119 (2009), 1211–1219.
Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18 (2016), 891–975.
De Backer, D., Biston, P., Devriendt, J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362 (2010), 779–789.
O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127 (2013), e362–e425.
Scheidt, S., Wilner, G., Mueller, H., et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 288 (1973), 979–984.
Thiele, H., Zeymer, U., Neumann, F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367 (2012), 1287–1296.
Thiele, H., Zeymer, U., Neumann, F.-J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382 (2013), 1638–1645.
Kawashima, D., Gojo, S., Nishimura, T., et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 57 (2011), 169–176.
Remy Bråthen, G.H., Holmøy, Erling, Ottersen, Ingunn Hegstad, Rapporter 2015/29 - SSB - Bemanningsbehov i spesialisthelsetjenesten mot 2040. 2015.
Tuseth, V., Pettersen, R.J., Epstein, A., et al. Percutaneous left ventricular assist device can prevent acute cerebral ischaemia during ventricular fibrillation. Resuscitation 80 (2009), 1197–1203.
Tuseth, V., Pettersen, R.J., Grong, K., et al. Randomised comparison of percutaneous left ventricular assist device with open-chest cardiac massage and with surgical assist device during ischaemic cardiac arrest. Resuscitation 81 (2010), 1566–1570.
Tuseth, V., Salem, M., Pettersen, R., et al. Percutaneous left ventricular assist in ischemic cardiac arrest. Crit Care Med 37 (2009), 1365–1372.
Kapur, N.K., Paruchuri, V., Urbano-Morales, J.A., et al. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 128 (2013), 328–336.
Kapur, N.K., Qiao, X., Paruchuri, V., et al. Mechanical pre-conditioning with acute circulatory support before reperfusion limits infarct size in acute myocardial infarction. JACC Heart Fail 3 (2015), 873–882.
Packer, E.J.S., Slettom, G., Solholm, A., et al. Left versus biventricular assist devices in cardiac arrest. ASAIO J 64 (2018), 489–496.
Schiller, P., Vikholm, P., Hellgren, L., The impella(R) recover mechanical assist device in acute cardiogenic shock: a single-centre experience of 66 patients. Interact Cardiovasc Thorac Surg 22 (2016), 452–458.
Seyfarth, M., Sibbing, D., Bauer, I., et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52 (2008), 1584–1588.
Ouweneel, D.M., Eriksen, E., Sjauw, K.D., et al. Impella CP versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: the IMPRESS trial. J Am Coll Cardiol 69 (2017), 278–287.
Matsuoka, Y., Ikenoue, T., Hata, N., et al. Hospitals’ extracorporeal cardiopulmonary resuscitation capabilities and outcomes in out-of-hospital cardiac arrest: a population-based study. Resuscitation 136 (2019), 85–92.
Ouweneel, D.M., Eriksen, E., Sjauw, K.D., et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69 (2017), 278–287.
Hemradj, V.V., Ottervanger, J.P., van't Hof, A.W., et al. Cardiogenic shock predicts long-term mortality in hospital survivors of STEMI treated with primary percutaneous coronary intervention. Clin Cardiol 39 (2016), 665–669.
Hochman, J.S., Sleeper, L.A., Webb, J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341 (1999), 625–634.
Ibanez, B., James, S., Agewall, S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39 (2018), 119–177.
